Cranmer, L. D., Loggers, E. T., Wagner, M. J., Schaub, S. K., Kim, E. Y., Roberts, J., Thompson, M. J., Mogal, H., Sharib, J., Chen, E. Y., Bandhlish, A., Chen, R., Moore, R., Morin, N., Siu, D., Johnson, R., Black, R. G., Maxwell, S., Yeung, C., Pollack, S. M. (2026). Phase II pilot study of pembrolizumab (PEM) and neoadjuvant radiation therapy (nRT) in high-risk soft tissue sarcomas (STS).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.11584